tirzepatide and lithium Lilly Shows Superiority in SURMOUNT-3 4 Eli Lilly Study Finds Zepbound

Some patients experience breakthrough weight loss when both GLP-1 and GIP receptors are engaged together, especially if genetic testing reveals dual-pathway activation

You may notice reduced cravings and improved portion control within weeks

Jastreboff et al.: Tirzepatide for Obesity Treatment and Diabetes Prevention

Step 2: Virtual Consultation Engage in an online meeting with a licensed provider who will evaluate your health details, weight loss ambitions, and current medications to formulate a plan tailored just for you

While rare, a fever can be part of a severe hypersensitivity or allergic reaction to the medication